已收盘 01-30 16:00:00 美东时间
-0.800
-0.85%
CF Industries (CF) declared $0.50/share quarterly dividend, in line with previous. Forward yield 2.18% Payable Feb. 27; for shareholders of record Feb. 13; ex-div Feb. 13. See CF Dividend Scorecard, Y...
01-28 05:32
CF Industries Holdings Inc. declares $0.50 per share dividend CF Industries Holdings Inc. has announced a quarterly dividend of $0.50 per share on its common stock, payable on February 27, 2026, to shareholders of record as of February 13, 2026. Disclaimer: This news brief was created by Public Tech
01-28 05:30
Exxon begins commercial CCS project with CF industries in Louisiana Jan 26 (Reuters) - Exxon Mobil XOM.N said on Monday it has begun its commercial operation of carbon capture and storage, or CCS, with ammonia producer CF Industries CF.N in Louisiana, starting in 2025. The project will transport and
01-27 06:33
ExxonMobil Expands Carbon Capture Operations in Texas and Louisiana Exxon Mobil Corporation announced progress in its carbon capture and storage (CCS) operations, highlighting several milestones achieved in 2025. The company began transporting and storing up to 2 million tonnes per annum (MTA) of CO
01-27 05:55
Horizon Bancorp, Inc. has announced that James B. Dworkin will retire from the Board of Directors on May 7, 2026, and Julie S. Freigang has resigned effective January 20, 2026. Both have served as independent directors and contributed significantly to the company's governance. Eric P. Blackhurst, Board Chairman, thanked them for their dedication and leadership, particularly in areas such as audit, wealth management, and cybersecurity. About Horiz...
01-26 15:30
今日重点评级关注:HC Wainwright & Co.:维持Soleno Therapeutics"买入"评级,目标价从110美元升至120美元;富国银行:维持Soleno Therapeutics"超配"评级,目标价从106美元升至114美元
01-21 11:42
RBC Capital analyst Andrew D. Wong maintains CF Industries Holdings (NYSE:CF) with a Sector Perform and raises the price target from $90 to $95.
01-20 23:46
今日重点评级关注:Benchmark:维持TNL Mediagene"投机性买入"评级,目标价从3.5美元升至14美元;康托·菲茨杰拉德:维持Eupraxia Pharmaceuticals"超配"评级,目标价从11美元升至19美元
01-16 10:04
今日重点评级关注:HC Wainwright & Co.:维持Enlivex Therapeutics"买入"评级,目标价从7美元升至13美元;BTIG:维持Oruka Therapeutics"买入"评级,目标价从63美元升至73美元
01-13 10:18